MetaCap

Cigna Group (CI) vs Natera (NTRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Natera (NTRA) has outperformed Cigna Group (CI) over the past year, gaining 18.5% versus a loss of 2.6%. Over five years, NTRA leads with a +188.8% price change compared with +34.1% for CI. Cigna Group is the larger company by market cap ($71.38 billion vs $39.64 billion), about 1.8 times the size, while Natera is growing revenue faster (+35.9% vs +11.2%).

Cigna Group pays a dividend yielding 2.28%, while Natera does not currently pay one. Cigna Group converts more of its revenue into profit, with a net margin of 2.2% versus -9.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CI-2.59%NTRA+18.54%
+95%+34%-26%
Nov 21, 20251 yearNov 20, 2026
CI+28.69%NTRA+164.97%
+320%+117%-86%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CI versus NTRA key metrics
MetricCINTRA
Share price$270.90$273.40
Market cap$71.38B$39.64B
1-day change-0.78%-5.70%
YTD return-1.57%+19.34%
1-year return-2.59%+18.54%
5-year return+34.09%+188.82%
P/E ratio (TTM)11.94—
Forward P/E8.14—
EPS (TTM)$22.68$-1.12
Dividend yield2.28%0.00%
Annual dividend$6.19$0.00
Revenue (latest FY)$274.90B$2.31B
Revenue growth (YoY)+11.24%+35.90%
Net income (latest FY)$5.96B$-208.16M
Gross margin21.79%—
Operating margin3.35%-13.44%
Net margin2.17%-9.03%
52-week high$318.05$437.41
52-week low$257.85$181.00
Distance from 52-week high-14.82%-37.50%
Analyst consensusbuystrong_buy
Avg. price target upside+27.13%+50.06%
Average volume1.66M1.77M
Shares outstanding263.50M145.00M
Employees65,6696,135
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NTRA has outperformed CI by 21.1 percentage points over the past year.
  • Cigna Group offers a meaningfully higher dividend yield (2.28% vs 0.00%).
  • Cigna Group is more profitable, keeping 2.2 cents of every revenue dollar as net income versus -9.0 cents for Natera.
  • Natera grew revenue faster in its latest fiscal year (+35.90% vs +11.24%).

About Cigna Group

CI stock →

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.

Health Care · Medical Specialities · 65,669 employees

About Natera

NTRA stock →

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.

Health Care · Medical Specialities · 6,135 employees

CI vs NTRA FAQ

Which is bigger, Cigna Group or Natera?

Cigna Group (CI) is larger, with a market capitalization of $71.38B compared with $39.64B for Natera (NTRA).

Which stock has performed better over the past year, CI or NTRA?

NTRA returned +18.54% over the past 12 months, compared with -2.59% for CI (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Cigna Group or Natera?

Cigna Group pays a dividend yielding 2.28%, while Natera does not currently pay a regular dividend.

Are Cigna Group and Natera in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons